NALP3-mediated inflammation is a principal cause of progressive renal failure in oxalate nephropathy

被引:178
|
作者
Knauf, Felix [1 ]
Asplin, John R. [2 ]
Granja, Ignacio [2 ]
Schmidt, Insa M. [1 ]
Moeckel, Gilbert W. [3 ]
David, Rachel J. [1 ]
Flavell, Richard A. [4 ,5 ]
Aronson, Peter S. [1 ,6 ]
机构
[1] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06520 USA
[2] Litholink, Chicago, IL USA
[3] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06520 USA
[4] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA
[5] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA
[6] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA
关键词
crystal nephropathy; inflammasome; NALP3; oxalate; NALP3; INFLAMMASOME; NLRP3; PLASMA;
D O I
10.1038/ki.2013.207
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Oxalate nephropathy with renal failure is caused by multiple disorders leading to hyperoxaluria due to either overproduction of oxalate (primary hyperoxaluria) or excessive absorption of dietary oxalate (enteric hyperoxaluria). To study the etiology of renal failure in crystal-induced kidney disease, we created a model of progressive oxalate nephropathy by feeding mice a diet high in soluble oxalate (high oxalate in the absence of dietary calcium). Renal histology was characterized by intratubular calcium-oxalate crystal deposition with an inflammatory response in the surrounding interstitium. Oxalate nephropathy was not found in mice fed a high oxalate diet that also contained calcium. NALP3, also known as cryopyrin, has been implicated in crystal-associated diseases such as gout and silicosis. Mice fed the diet high in soluble oxalate demonstrated increased NALP3 expression in the kidney. Nalp3-null mice were completely protected from the progressive renal failure and death that occurred in wild-type mice fed the diet high in soluble oxalate. NALP3 deficiency did not affect oxalate homeostasis, thereby excluding differences in intestinal oxalate handling to explain the observed phenotype. Thus, progressive renal failure in oxalate nephropathy results primarily from NALP3-mediated inflammation.
引用
收藏
页码:895 / 901
页数:7
相关论文
共 50 条
  • [22] Rapidly progressive renal failure as the onset of an IgA nephropathy in an elderly patient
    Heras, M.
    Saiz, A.
    Pardo, J.
    Fernandez-Reyes, M. J.
    Sanchez, R.
    Alvarez-Ude, F.
    NEFROLOGIA, 2011, 31 (02): : 234 - 236
  • [23] Treatment of progressive renal failure in idiopathic membranous nephropathy with azathioprine and prednisolone
    Baker, LRI
    Tucker, B
    Macdougall, IC
    Oommen, R
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1998, 13 (10) : 2704 - 2704
  • [24] A rare cause of coagulopathy in a patient with rapidly progressive renal failure
    Prabakaran, Rudreshwar
    Sethi, Jasmine
    Rathi, Manish
    Kohli, Harbir Singh
    Malhotra, Pankaj
    Gupta, Krishan Lal
    INDIAN JOURNAL OF NEPHROLOGY, 2020, 30 (02) : 110 - 112
  • [25] Acute renal failure and a "rejuvenating powder" - Vitamin C-induced oxalate nephropathy
    Borceux, Pauline
    Aydin, Selda
    Demoulin, Nathalie
    Devresse, Arnaud
    KIDNEY INTERNATIONAL, 2020, 97 (01) : 219 - 220
  • [26] NITROPRUSSIDE NEPHROPATHY - AN UNRECOGNIZED CAUSE OF ACUTE RENAL-FAILURE (ARF)
    COTTERELL, L
    ELZINGA, LW
    KIDNEY INTERNATIONAL, 1989, 35 (01) : 224 - 224
  • [27] REFLUX NEPHROPATHY AS A CAUSE OF END-STAGE RENAL-FAILURE
    BROWN, JH
    MCGEOWN, MG
    CLINICAL NEPHROLOGY, 1988, 29 (02) : 103 - 104
  • [28] Chronic renal failure secondary to oxalate nephropathy: A preventable complication after jejunoileal bypass
    Hassan, I
    Juncos, LA
    Milliner, DS
    Sarmiento, JM
    Sarr, MG
    MAYO CLINIC PROCEEDINGS, 2001, 76 (07) : 758 - 760
  • [29] Crystalline nephropathy due to APRT deficiency: A preventable cause of renal and renal allograft failure
    Rajput, Prashant
    Virani, Zaheer A.
    Shah, Bharat V.
    INDIAN JOURNAL OF NEPHROLOGY, 2020, 30 (04) : 290 - 292
  • [30] REFLUX NEPHROPATHY AS A CAUSE OF END-STAGE RENAL-FAILURE
    NIYAMATHULLAH, MM
    KAKRE, N
    THOMAS, PP
    JACOB, CK
    KIRUBAKARAN, MG
    GOPALAKRISHNAN, G
    SHASTRY, JCM
    CLINICAL NEPHROLOGY, 1989, 32 (01) : 49 - 49